CANINSULIN INSULIN FOR DOGS AND CATS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

caninsulin insulin for dogs and cats

intervet australia pty limited - insulin - parenteral liquid/solution/suspension - insulin hormone active 40.0 iu/ml - endocrine system - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - insulin deficiency

CANINSULIN VETPEN INSULIN FOR DOGS AND CATS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

caninsulin vetpen insulin for dogs and cats

intervet australia pty limited - insulin - parenteral liquid/solution/suspension - insulin hormone active 40.0 iu/ml - endocrine system - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - insulin deficiency

Caninsulin 40 IU/ml Suspension for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

caninsulin 40 iu/ml suspension for injection

intervet ireland limited - insulin - suspension for injection - 40 international unit(s)/millilitre - insulin (pork) - cats, dogs - hormone

Insulin aspart Sanofi European Union - English - EMA (European Medicines Agency)

insulin aspart sanofi

sanofi winthrop industrie - insulin aspart - diabetes mellitus - drugs used in diabetes - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Insulin Human Winthrop European Union - English - EMA (European Medicines Agency)

insulin human winthrop

sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drugs used in diabetes - diabetes mellitus where treatment with insulin is required. insulin human winthrop rapid is also suitable for the treatment of hyperglycaemic coma and ketoacidosis, as well as for achieving pre-, intra- and postoperative stabilisation in patients with diabetes mellitus.

Insulin lispro Sanofi European Union - English - EMA (European Medicines Agency)

insulin lispro sanofi

sanofi winthrop industrie - insulin lispro - diabetes mellitus - drugs used in diabetes - for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. insulin lispro sanofi is also indicated for the initial stabilisation of diabetes mellitus.

CANINSULIN New Zealand - English - Ministry for Primary Industries

caninsulin

schering-plough animal health limited - insulin - insulin 0.04 thou iu/ml - endocrine agent (hormone)

Caninsulin 40 IU/ml inj. susp. i.m./s.c. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

caninsulin 40 iu/ml inj. susp. i.m./s.c. vial

intervet international b.v. - insulin porcine 40 iu/ml - suspension for injection - 40 iu/ml - insulin zinc suspension, crystalline 28 iu/ml; insulin zinc suspension, amorphous 12 iu/ml - insulin (pork) - dog; cat

Caninsulin 40 IU/ml inj. susp. s.c./i.m. cartr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

caninsulin 40 iu/ml inj. susp. s.c./i.m. cartr.

intervet international b.v. - insulin porcine 40 iu/ml - suspension for injection - 40 iu/ml - insulin zinc suspension, amorphous 12 iu/ml; insulin zinc suspension, crystalline 28 iu/ml - insulin (pork) - dog; cat

OPTISULIN SOLOSTAR 100IU/mL insulin glargine (rbe) 3mL solution for injection injector pen Australia - English - Department of Health (Therapeutic Goods Administration)

optisulin solostar 100iu/ml insulin glargine (rbe) 3ml solution for injection injector pen

sanofi-aventis australia pty ltd - insulin glargine, quantity: 3.6378 mg/ml - injection, solution - excipient ingredients: water for injections; metacresol; glycerol; zinc chloride; sodium hydroxide; hydrochloric acid - insulin glargine is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 diabetes mellitus in adults and children and type 2 diabetes mellitus in adults who require insulin for control of hyperglycaemia.